Source: Neuropharmacology. Unidade: FMRP
Subjects: ESQUIZOFRENIA, CANABINOIDES, COGNIÇÃO
ABNT
ALMEIDA, Valéria et al. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology, v. 155, p. 44-53, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2019.05.015. Acesso em: 17 out. 2024.APA
Almeida, V., Levin, R., Peres, F. F., Suiama, M. A., Vendramini, A. M., Santos, C. M., et al. (2019). Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology, 155, 44-53. doi:10.1016/j.neuropharm.2019.05.015NLM
Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND da, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit [Internet]. Neuropharmacology. 2019 ; 155 44-53.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.05.015Vancouver
Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND da, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit [Internet]. Neuropharmacology. 2019 ; 155 44-53.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.neuropharm.2019.05.015